MRMaral J. Rouhani

Maral J. Rouhani

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Maral J. Rouhani has a total of 59 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Gender‐Affirming Laryngeal Surgery: The Effects of the Modified Wendler's Glottoplasty on Voice Pitch and Quality of Life

    by Maral J. Rouhani, Chadwan Al Yaghchi

    Objective: To describe the effects of the Modified Wendler's Glottoplasty (MWG) technique on voice pitch and quality of life (QoL) using preoperative and postoperative outcome measures. Study Design: Single institution retrospective review. Setting: Tertiary care private healthcare facility. Methods: A retrospective cohort study was performed of all transgender patients undergoing voice feminisation surgery using the MWG technique by a single surgeon from September 2020 to August 2024. Demographic data was extracted in addition to preoperative and postoperative speaking and reading fundamental frequencies ( f 0 ) and Ten Question Voice Handicap Index (VHI‐10) and TransWoman Voice Questionnaire (TWVQ) scores. Results: 300 patients were included in the study with an average age of 36.9 years. Mean preoperative free continuous speech f 0 was 125.3 Hz; at 4 weeks, mean f 0 statistically significantly increased from baseline to 186.2 Hz ( P < .0001) and at 4 months, mean f 0 statistically significantly increased from baseline to 182.6 Hz ( P < .00034). Mean preoperative reading f 0 was 127.7 Hz; at 4 weeks, mean f 0 statistically significantly increased from baseline to 191.2 Hz ( P < .0001) and at 4 months, mean f 0 statistically significantly increased from baseline to 187.8 Hz ( P < .0001). Mean VHI‐10 score was 20.32 preoperatively; this significantly reduced to a mean score of 11.53 at 4 months ( P < .0001). Mean TWVQ score was 93.27 preoperatively; this significantly reduced to a mean score of 52.13 at 4 months ( P < .0001). Conclusion: This study provides a comprehensive assessment of the outcomes associated with MWG in transgender women seeking gender‐affirming voice surgery and demonstrates a significant improvement in vocal pitch and voice‐related QoL following surgery.


  • Translating premalignant biology to accelerate non-small-cell lung cancer interception

    by Sarah A. Mazzilli, Zahraa Rahal, Maral J. Rouhani, Sam M. Janes, Humam Kadara, Steven M. Dubinett, Avrum E. Spira

    Over the past decade, substantial progress has been made in the development of targeted and immune-based therapies for patients with advanced non-small-cell lung cancer. To further improve outcomes for patients with lung cancer, identifying and intercepting disease at the earliest and most curable stages are crucial next steps. With the recent implementation of low-dose computed tomography scan screening in populations at high risk, there is an emerging unmet need for new diagnostic, prognostic and therapeutic tools to help treat patients suspected of harbouring premalignant lesions and minimally invasive non-small-cell lung cancer. Continued advances in the identification of the earliest drivers of lung carcinogenesis are poised to address these unmet needs. Employing multimodal approaches to chart the temporal and spatial maps of the molecular events driving lung premalignant lesion progression will refine our understanding of early carcinogenesis. Elucidating the molecular drivers of premalignancy is critical to the development of biomarkers to detect those incubating a premalignant lesion, to stratify risk for progression to invasive cancer and to identify novel therapeutic targets to intercept that process. In this Review, we summarize emerging insights into the earliest cellular and molecular events associated with lung squamous and adenocarcinoma carcinogenesis and highlight the growing opportunity for translating these insights into clinical tools for early detection and disease interception to transform the outcomes for those at risk for lung cancer.


  • Open Access

    Lentiviral expression of wild-type LAMA3A restores cell adhesion in airway basal cells from children with epidermolysis bullosa

    by Chun Hang Lau, Maral J. Rouhani, Elizabeth F. Maughan, Jessica C. Orr, Krishna K. Kolluri, David R. Pearce, Elizabeth K. Haughey, Liam Sutton, Sam Flatau, Pablo Lopez Balboa, et al.


  • Assessment of swallow function pre‐ and post‐endoscopic CO2 laser medial arytenoidectomy: a case series

    by Maral J. Rouhani, Isobel Morley, Lindsay Lovell, Justin Roe, Yadsan Devabalan, Rohan Bidaye, Guri Sandhu, Chadwan Al Yaghchi


  • Suspension laryngoscopy experiences in a tertiary airway service: A prospective study of 150 procedures

    by Elizabeth F. Maughan, Anthony Rotman, Maral J. Rouhani, Gerard Thong, James Poncia, John Myatt, Chadwan Al Yaghchi, Gurpreet Sandhu

    Objectives: In most cases, suspension laryngoscopy (SL) is efficient, bloodless and with minimal post‐procedure discomfort. We aimed to identify predictive patient factors for acceptable surgical views at SL as well as quantify our tertiary airway unit's complication rates.Design: Prospective cohort study of 150 consecutive microlaryngoscopy procedures involving SL over an 8‐month period between November 2019 and July 2020. Patients were assessed preoperatively for pre‐existing oral, temporomandibular, dental, pharyngeal or laryngeal pathology, interincisor distance and qualitative gross limitations to neck extension and forward head posture. Intraoperatively, the laryngoscopic view was graded by anaesthetic and surgical teams, and complications were recorded on patient interview in recovery.Setting: Tertiary adult airway service for predominantly benign pathology.Results: Adequate surgical views were obtained in 149/150 procedures. BMI had a weak positive correlation with a more difficult view (r = .22, p = .008) but did not correlate with a statistically significant increase in any complication. There was a weak negative correlation between age and interincisor gap (r = −.20, p = .014), and wider mouth opening correlated very weakly with a lower incidence of sore throat (r = −.19, p = .023). Gross macroglossia showed a significant moderate positive correlation with tongue symptoms (r = .45, p = 1.611 × 10−8).Conclusion: In the context of an experienced airway unit with a high caseload of predominantly benign pathology, SL is very effective and safe with low associated morbidity and no mortality. The most common complication of SL is temporary sore throat and there remain recognised risks of temporary tongue and dental symptoms.


  • Open Access

    Sarcoidosis of the ear, nose and throat: A review of the literature

    by Nicholas Cereceda‐Monteoliva, Maral J. Rouhani, Elizabeth F Maughan, Anthony Rotman, Nara Orban, Chadwan Al Yaghchi, Gurpreet Sandhu

    Objectives: Sarcoidosis is a multisystemic inflammatory disease with extrathoracic manifestations, most commonly affecting the young and middle‐aged, female and Black populations. Diagnosis usually requires evidence of non‐caseating granulomata and, when treated, prognosis is usually favourable. We aim to establish the incidence, clinical features and optimal treatment of ENT manifestations of this disease.Design: We performed a PubMed literature review to determine the evidence base supporting this.Results: ENT manifestations are present in 5%‐15% of patients with sarcoidosis, often as a presenting feature, and require vigilance for swift recognition and coordinated additional treatment specific to the organ. Laryngeal sarcoidosis presents with difficulty in breathing, dysphonia and cough, and may be treated by speech and language therapy (SLT) or intralesional injection, dilatation or tissue reduction. Nasal disease presents with crusting, rhinitis, nasal obstruction and anosmia, usually without sinus involvement. It is treated by topical nasal or intralesional treatments but may also require endoscopic sinus surgery, laser treatment or even nasal reconstruction. Otological disease is uncommon but includes audiovestibular symptoms, both sensorineural and conductive hearing loss, and skin lesions.Conclusions: The consequences of ENT manifestations of sarcoidosis can be uncomfortable, disabling and even life‐threatening. Effective management strategies require good diagnostic skills and use of specific therapies combined with established treatments such as corticosteroids. Comparisons of treatment outcomes are needed to establish best practice in this area.


  • In Response to Voice, Swallow and Airway Outcomes Following Tracheostomy for COVID‐19

    by Maral J. Rouhani, Guri Sandhu, Chadwan Al Yaghchi


  • Open Access

    A Prospective Study of Voice, Swallow, and Airway Outcomes Following Tracheostomy for COVID‐19

    by Maral J. Rouhani, Gemma Clunie, Gerard Thong, Lindsay Lovell, Justin Roe, Margaret Ashcroft, Andrew Holroyd, Guri Sandhu, Chadwan Al Yaghchi

    Objective: The COVID‐19 pandemic has led to unprecedented demands on healthcare with many requiring intubation. Tracheostomy insertion has often been delayed and the enduring effects of this on voice, swallow, and airway outcomes in COVID‐19 tracheostomy patients are unknown. The aim of this study was to prospectively assess these outcomes in this patient cohort following hospital discharge.Methods: All COVID‐19 patients who had undergone tracheostomy insertion, and were subsequently decannulated, were identified at our institution and followed up 2 months post‐discharge. Patient‐reported (PROMS) and clinician‐reported outcome measures, endoscopic examination, and spirometry were used to assess voice, swallow, and airway outcomes.Results: Forty‐one patients were included in the study with a mean age of 56 years and male:female ratio of 28:13. Average duration of endotracheal intubation was 24 days and 63.4% of tracheostomies were performed at day 21 to 35 of intubation. 53.7% had an abnormal GRBAS score and 30% reported abnormal swallow on EAT‐10 questionnaire. 81.1% had normal endoscopic examination of the larynx, however, positive endoscopic findings correlated with the patient self‐reported VHI‐10 (P = .036) and EAT‐10 scores (P = .027). 22.5% had spirometric evidence of fixed upper airway obstruction using the Expiratory‐Disproportion Index (EDI) and Spearman correlation analysis showed a positive trend between abnormal endoscopic findings and EDI scores over 50 (P < .0001).Conclusion: The preliminary results of this study reveal a high incidence of laryngeal injury among patients who underwent intubation and tracheostomy insertion during the COVID‐19 pandemic. As these patients continue to be followed up, the evolution of these complications will be studied.Level of Evidence: 3 Laryngoscope, 131:E1918–E1925, 2021


  • Role of local anaesthetic nerve block in endoscopic sinus surgery: A systematic review and meta‐analysis

    by E. Shamil, M.J. Rouhani, S. Basetti, F. Bast, C. Hopkins, P. Surda

    Objective: The aim of the study was to perform a systematic review of existing evidence on the role of local anaesthetic nerve block (LAB) in patients undergoing endoscopic sinus surgery (ESS).Design: The databases searched were the Cochrane Register of Controlled Trials, MEDLINE and Embase using the Ovid portal (1946‐2017).Results: Seven randomised controlled trials were included. Due to considerable heterogeneity of data, only two studies were pooled into meta‐analysis which demonstrated a statistically significantly better surgical field quality during ESS in the LAB group compared with the control group (MD −0.86; 95% CI −2.24, 0.51; P = .009). No adverse events related to LAB toxicity were reported.Conclusions: Sphenopalatine ganglion LAB with adrenaline carries relatively low risk of morbidity, but may improve the quality of the surgical field in terms of bleeding. However, there are limitations of the study due to heterogeneity of methods, quality and size of the studies. Well‐conducted large RCTs are needed using standardised inclusion criteria, balanced baseline characteristics of cohorts, and validated subjective and objective outcome measures.


  • Open Access

    Leptospirosis presenting as severe cardiogenic shock: A case report

    by E Forbat, Mj Rouhani, C Pavitt, S Patel, R Handslip, S Ledot

    Background: Leptospirosis is a rare infectious illness caused by the Spirochaete Leptospira. It has a wide-varying spectrum of presentation. We present a rare case of severe cardiogenic shock secondary to leptospirosis, in the absence of its common clinical features. Case presentation: A 36-year-old woman presented to our unit with severe cardiogenic shock and subsequent multi-organ failure. Her clinical course was characterised by ongoing pyrexia of unknown origin with concurrent cardiac failure. She was initially managed with broad-spectrum antibiotics and inotropes. Percutaneous cardiac biopsy excluded major causes of myocarditis. On day 21 after presentation, she was found to be IgM-positive for leptospirosis. Conclusions: This is a rare case of severe cardiogenic shock secondary to leptospirosis infection. The case also highlights the importance of obtaining a thorough social history when assessing a patient with an unusual presentation, as clues can often be missed.